Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 08/01/2006


Featured Articles

-CoQ10 Health Benefits…*

-CoQ10: Absorption and Pharmacokinetics…*

-Sytrinol: An Interview with Zheng-Xian Liu, Ph.D…*

Product Highlights

-Entire month of August: 12% summer discount on 30 and 60 count bottle sizes of CoQ10 30-120 mg. Read more about our weekly product specials...

New Products

-Q-Gel® (Hydrosoluble™ CoQ10)

Featured Abstracts

-CoQ10 supplementation helps maintain healthy glucose metabolism and systolic and diastolic cardiovascular function…*

-Higher plasma CoQ10 levels promote cellular health, particularly for the skin…*

-The antioxidant actions of CoQ10 promote healthy function of the hippocampus and cerebral cortex…*

-Cinnamon supports healthy glucose metabolism and vascular health…*

-Tocotrienols maintain healthy neuron function in the presence of glutamate…*

Frequently Asked Questions

-Can probiotics be taken concurrently with antibiotic medications or supplements?

Quick Fact

-Not All CoQ10 is Created Equal


Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes

OBJECTIVE: Our objective was to assess effects of dietary supplementation with coenzyme Q10 (CoQ) on blood pressure and glycaemic control in subjects with type 2 diabetes, and to consider oxidative stress as a potential mechanism for any effects. SUBJECTS AND DESIGN: Seventy-four subjects with uncomplicated type 2 diabetes and dyslipidaemia were involved in a randomised double blind placebo-controlled 2x2 factorial intervention. SETTING: The study was performed at the University of Western Australia, Department of Medicine at Royal Perth Hospital, Australia. INTERVENTIONS: Subjects were randomly assigned to receive an oral dose of 100 mg CoQ twice daily (200 mg/day), 200 mg fenofibrate each morning, both or neither for 12 weeks. MAIN OUTCOME MEASURES: We report an analysis and discussion of the effects of CoQ on blood pressure, on long-term glycaemic control measured by glycated haemoglobin (HbA(1c)), and on oxidative stress assessed by measurement of plasma F2-isoprostanes. RESULTS: Fenofibrate did not alter blood pressure, HbA(1c), or plasma F2-isoprostanes. There was a 3-fold increase in plasma CoQ concentration (3.4+/-0.3 micro mol/l, P<0.001) as a result of CoQ supplementation. The main effect of CoQ was to significantly decrease systolic (-6.1+/-2.6 mmHg, P=0.021) and diastolic (-2.9+/-1.4 mmHg, P=0.048) blood pressure and HbA(1c) (-0.37+/-0.17%, P=0.032). Plasma F2-isoprostane concentrations were not altered by CoQ (0.14+/-0.15 nmol/l, P=0.345). CONCLUSIONS: These results show that CoQ supplementation may improve blood pressure and long-term glycaemic control in subjects with type 2 diabetes, but these improvements were not associated with reduced oxidative stress, as assessed by F2-isoprostanes. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.


For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure